SAN DIEGO, June 2, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the acceptance of seven key oncology research abstracts authored in collaboration with Illumina at the American Society of Clinical…
News Ticker
- [ March 23, 2023 ] Schmidt Futures Fellows Seek to Expand Promise of AI in STEM Fields News
- [ March 23, 2023 ] Darrell and Dorthy Ann Fanestil Establish Endowed Chair in Nephrology-Hypertension With $2M Gift News
- [ March 23, 2023 ] CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction News
- [ March 23, 2023 ] New Braintrust Seeks to Launch Era of North American Regional Competitiveness News
- [ March 23, 2023 ] California Governor Gavin Newsom Visits UC San Diego’s Nimitz Marine Facility News
Copyright © 2022 Biotech Networks, LLC
